NCT00937183
Phase I/II Study of Adjuvant Dendritic Cell-Lymphoma Cell Hybrids and/or Dendritic Cells Pulsed With Tumor Lysates in Patients With Indolent B-Cell Lymphoma or Multiple Myeloma
Nowotwór
chłoniak B-komórkowy
Chorzy
bez progresji
Faza badania
II
Sponsor badania
CO-I Warszawa
Termin
-
Linki
Dane kontaktowe
CO-I Warszawa, Jan Walewski, MD Ph: 48-22-546-2223 walewski@coi.waw.pl